LIGAND PHARMACEUTICALS INCORPORATED Deferred Revenue and Credits, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Deferred Revenue and Credits, Current of $426.00 thousand as of 2011-09-30, per its 10-Q/A filed 2012-02-10.
Discontinued › Notes › Revenue Recognition and Deferred Revenue
us-gaap:DeferredRevenueAndCreditsCurrent · last filed 2012-11-14
- 2011-09-30: Deferred Revenue and Credits, Current $426.00K.
- 2011-06-30: Deferred Revenue and Credits, Current $851.00K.
- 2010-12-31: Deferred Revenue and Credits, Current $1.70M.
| Period end | Deferred Revenue and Credits, Current |
|---|---|
| 2011-09-30 | $426.00K 10-Q/A · filed 2012-02-10 |
| 2011-06-30 | $851.00K 10-Q/A · filed 2012-02-10 |
| 2010-12-31 | $1.70M 10-K/A · filed 2012-11-14 |